Liabilities, Current in USD of Can-Fite BioPharma Ltd. from Q4 2018 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
Can-Fite BioPharma Ltd. quarterly Liabilities, Current history and change rate from Q4 2018 to Q2 2025.
  • Can-Fite BioPharma Ltd. Liabilities, Current for the quarter ending 30 Jun 2025 was $2.12M, a 6.69% increase year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Change (%)

Can-Fite BioPharma Ltd. Quarterly Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $2.12M +$133K +6.69% 30 Jun 2025 6-K 28 Aug 2025
Q4 2024 $2.05M +$32K +1.58% 31 Dec 2024 6-K 28 Aug 2025
Q2 2024 $1.99M -$246K -11% 30 Jun 2024 6-K 29 Aug 2024
Q4 2023 $2.02M -$482K -19.3% 31 Dec 2023 20-F 14 Apr 2025
Q2 2023 $2.23M +$80K +3.72% 30 Jun 2023 6-K 31 Aug 2023
Q4 2022 $2.5M -$228K -8.35% 31 Dec 2022 20-F 28 Mar 2024
Q2 2022 $2.15M -$206K -8.73% 30 Jun 2022 6-K 25 Aug 2022
Q4 2021 $2.73M +$1.46M +115% 31 Dec 2021 20-F 30 Mar 2023
Q2 2021 $2.36M +$858K +57.2% 30 Jun 2021 6-K 26 Aug 2021
Q4 2020 $1.27M -$2M -61.2% 31 Dec 2020 20-F 24 Mar 2022
Q2 2020 $1.5M 30 Jun 2020 6-K 27 Aug 2020
Q4 2019 $3.27M +$152K +4.87% 31 Dec 2019 20-F 25 Mar 2021
Q4 2018 $3.12M 31 Dec 2018 6-K 01 Jun 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.